Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 2Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 2Solitary Fibrous Tumor, Pleural 1Solid Tumors 1Sarcoma 1Retinoblastoma 1Neuroblastoma 1Mesothelioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Filgrastim 6Granulocyte Colony-Stimulating Factor 5Carboplatin 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Etoposide 3Cyclophosphamide 3Topotecan 2racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1cixutumumab 1becatecarin 1alvocidib 1Vincristine 1Thrombopoietin 1Temozolomide 1Sirolimus 1Simvastatin 1Radiotherapy 1Nivolumab 1Methotrexate 1Melphalan 1Leucovorin 1LY2940680 1Itraconazole 1Immunologic Techniques 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Methotrexate × Other solid neoplasm × Clear all
NCT00003273 2015-12-03

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NYU Langone Health

Phase 2 Withdrawn
CNSOther solid neoplasmSarcoma

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡